Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPT | AZN | AMGN | GILD | BMY |
| Company | Rapt Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 57.98 | 203.22 | 380.00 | 148.92 | 61.70 |
| High | 58.02 | 203.22 | 380.00 | 148.92 | 62.43 |
| Low | 57.98 | 200.55 | 370.82 | 146.10 | 61.47 |
| Latest | 58.02 | 201.86 | 378.26 | 147.75 | 62.11 |
| Change | +0.04 | +0.10 | +1.26 | -0.08 | +0.89 |
| % Change | +0.07% | +0.05% | +0.33% | -0.05% | +1.45% |
| Volume | 11,125,200 | 783,455 | 692,444 | 1,410,374 | 4,469,663 |
| 20-Day Average Volume | 4,642,485 | 2,389,432 | 2,905,514 | 7,590,978 | 13,845,640 |
| Previous Close | 57.98 | 201.76 | 377.00 | 147.83 | 61.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 57.82 | 201.59 | 375.92 | 150.15 | 60.79 |
| 20-Day Raw Stochastic | 100.00% | 58.54% | 71.93% | 32.54% | 89.36% |
| 20-Day Relative Strength | 76.09 | 55.80 | 58.69 | 56.49 | 64.39 |
| Weighted Alpha | +230.04 | +38.22 | +26.55 | +35.48 | +17.14 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/23/26 | -1.95% since 02/25/26 | -1.76% since 02/25/26 | +0.40% since 02/25/26 | +1.47% since 02/25/26 |
| Low | 57.91 on 02/24/26 | 197.10 on 03/03/26 | 370.82 on 03/04/26 | 143.09 on 02/26/26 | 60.43 on 03/03/26 |
| High | 58.02 on 03/02/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +0.59% since 02/02/26 | +7.64% since 02/04/26 | +3.10% since 02/04/26 | +1.01% since 02/04/26 | +7.95% since 02/04/26 |
| Low | 57.61 on 02/04/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 58.00 on 02/05/26 |
| High | 58.02 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +79.46% since 12/02/25 | +12.06% since 12/04/25 | +10.99% since 12/04/25 | +20.46% since 12/04/25 | +19.73% since 12/04/25 |
| Low | 29.77 on 01/06/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 58.02 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +388.80% since 09/02/25 | +23.36% since 09/04/25 | +34.79% since 09/04/25 | +30.98% since 09/04/25 | +33.22% since 09/04/25 |
| Low | 11.19 on 09/04/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 58.02 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,607,792 | 312,911,168 | 203,228,640 | 183,519,280 | 124,672,944 |
| Shares Outstanding, K | 27,711 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -129,870,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -17,580,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.49 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.24 | 17.65 | 18.41 | 10.14 |